Fanconi Anemia

Fanconi Anaemia (FA)is an uncommon hereditary haematologic condition that predominantly impacts bone marrow, resulting in diminished blood cell production and increased susceptibility to bone marrow failure, leukaemia, and other malignancies. It happens when genes that stabilise DNA change, which makes cells very easy to harm. Fatigue, frequent infections, easy bruising, abnormal bleeding, and developmental issues like bone defects, short stature, or kidney difficulties are common symptoms.

Genetic testing, chromosomal breakage analysis, and bone marrow examination are all common parts of the diagnosis. Most often, the illness manifests in children at a very young age. Without therapy, progressive bone marrow failure might cause serious problems that could kill you.

Blood transfusions, androgen therapy, growth hormones, and bone marrow or stem cell transplantation are some of the ways to treat bone marrow loss. Bone marrow or stem cell transplantation is still the best long-term solution. Researchers are looking into new developments in gene therapy, which gives us hope for future therapies.

To improve quality of life, people with Fanconi Anaemia need regular checkups, early cancer screenings, and supportive care. Patients' outcomes are slowly getting better because of better medical care and research, but they will need medical care for the rest of their lives.